OpGen (OPGN)
(Delayed Data from NSDQ)
$2.54 USD
-0.52 (-16.93%)
Updated Jun 3, 2024 03:59 PM ET
After-Market: $2.64 +0.10 (3.86%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
OpGen, Inc. [OPGN]
Reports for Purchase
Showing records 61 - 80 ( 106 total )
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
Merger Completion; Strategic Reprioritization; Reiterate Buy; Instituting $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
Shareholder votes on Curetis merger coming
Provider: Edison Investment Research Limited
Analyst: JACOBS M
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
1Q19 Financial Results Reported; Reiterate Buy; Lower Price Target to $1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Rapid and effective diagnosis of infection
Provider: Edison Investment Research Limited
Analyst: JACOBS M
Company: OpGen, Inc.
Industry: Medical Services
2018 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
Clinical Trial Completed for Initial 510(k) Submission; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
CDC Contract for Mobile-Based Antimicrobial Stewardship Completed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Marketing Approval in Colombia; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
3Q18 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Acuitas Clinical Verification Study Update; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Collaboration with QIAGEN; Reiterate Buy and Lower Price Target to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Partnership With New York State and Merck to Detect Antimicrobial-Resistant Infections; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Company: OpGen, Inc.
Industry: Medical Services
2Q18 Financial Results Reported; 510(k) Filing in 2H18; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: OpGen, Inc.
Industry: Medical Services
Debt Terms Revised; Reiterate Buy and Lowering Price Target to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R